Revolution Medicines, Inc. ($RVMD)
Wang Xiaolin โ EVP, Clinical Development
Shares
34,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 25, 2026
EPS:Est: -1.56
Transaction Details
| Insider | Wang Xiaolin |
|---|---|
| Title | EVP, Clinical Development |
| Transaction Date | Mar 1, 2026 |
| Expiration Date | Feb 28, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 3, 2026 |
| Shares Purchased | 34,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 34,000 |
| Derivative | Derivative |
| Accession Number | 0001610717-26-000085 |
| Document | View SEC Filing |